Jennifer  Ku  to  United States
                            
                            
                                This is a "connection" page, showing publications  Jennifer  Ku  has written about  United States.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.867
         
        
        
     
 
    
        
        - 
            Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. Am J Ophthalmol. 2024 07; 263:133-140.
            
            
                Score: 0.122
             
- 
            Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest. 2024 May; 165(5):1058-1069.
            
            
                Score: 0.120
             
- 
            Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 2023 06 29; 41(29):4212-4219.
            
            
                Score: 0.116
             
- 
            Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clin Infect Dis. 2023 02 08; 76(3):e1408-e1415.
            
            
                Score: 0.113
             
- 
            Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States. Chest. 2022 02; 161(2):365-369.
            
            
                Score: 0.102
             
- 
            Limited Validity of Diagnosis Code-based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data. Ann Am Thorac Soc. 2021 07; 18(7):1246-1249.
            
            
                Score: 0.101
             
- 
            Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients. Emerg Infect Dis. 2021 03; 27(3):982-985.
            
            
                Score: 0.099
             
- 
            Risk Factors for Recurrent Urinary Tract Infections Among Women in a Large Integrated Health Care Organization in the United States. J Infect Dis. 2024 Nov 15; 230(5):e1101-e1111.
            
            
                Score: 0.032
             
- 
            Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
            
            
                Score: 0.031
             
- 
            mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States. Nat Commun. 2023 09 20; 14(1):5851.
            
            
                Score: 0.030